Glycan Therapeutics LLC entered the industry of Biological Research in 2013 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 541712, which describes it as a Biological Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Biological Research. The business provides service to the B2B market.
To acquire more information, please contact Jian Liu by calling (919) 962-4729 during business hours. You can also write to the business’ Single Location at 250 Bell Tower Drive Cb7063, Chapel Hill, North Carolina NC 27599. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Glycan Therapeutics LLC |
| Representative: | Jian Liu |
| Place of Business: | 250 Bell Tower Drive Cb7063, Chapel Hill, NC 27599 |
| Contact Number: | (919) 962-4729 |
| Type of Service: | Biological Research |
| SIC Number: | 8731 |
| NAICS Number: | 541712 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2013 |
| Income/Year: | $50.000 to $99.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Glycan Therapeutics LLC is a company operating from Orange, North Carolina providing professional Biological Research and relevant B2B variables. It was founded in 2013 and registered with the SIC code 8731 as Biological Research, and with the NAICS code 541712 as Biological Research.
With a current employee count of 1 to 4, Glycan Therapeutics LLC has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative Jian Liu at (919) 962-4729 for related queries, or to locate its Single Location using the coordinates 35.927859,-79.0321.
The Single Location can also be found at the street address 250 Bell Tower Drive Cb7063 in Chapel Hill, North Carolina 27599 and can be engaged online through the company website at , the company Twitter , and Facebook page .